4 news items
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
Long
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
AGEN
LGND
7 May 24
cells, downregulating intratumoral regulatory T cells, activating myeloid cells and inducing long-term memory responses
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
ALDX
LGND
MRK
27 Feb 24
Long
Ligand Pharmaceuticals's Earnings: A Preview
LGND
26 Feb 24
, shares are up 3.87%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release
- Prev
- 1
- Next